TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19204028

Group type: EXPERIMENTAL
Intervention: Phenylalanine-restricted diet
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo phase
Number of subjects: 34
Study: 16970170

Group type: EXPERIMENTAL
Intervention: Huzhangdanshenyin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 90
Study: 12517460

Group type: EXPERIMENTAL
Intervention: Primary PTCA
Number of subjects: 7739

Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 7739
Study: 11073141

Group type: EXPERIMENTAL
Intervention: Cefminox 2 g/12 h
Number of subjects: 160

Group type: COMPARATOR
Intervention: Metronidazole 500 mg/8 h and Gentamicin 80 mg/8 h (M+G)
Number of subjects: 160
Study: 8654159

Group type: EXPERIMENTAL
Intervention: Recombinant IFN-alpha
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Leukocyte IFN-alpha
Number of subjects: 60

Group type: COMPARATOR
Intervention: IFN-beta
Number of subjects: 60
Study: 1529929

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (short-term) with or without long-acting nitrates (chronic)
Number of subjects: 0
Study: 3924317

Group type: EXPERIMENTAL
Intervention: Ultrasound scanning
Number of subjects: 51
Study: 31127782

Group type: EXPERIMENTAL
Intervention: INT+MNT
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: INT-Only
Number of subjects: 32
Study: 28374550

Group type: EXPERIMENTAL
Intervention: Parental beliefs about child's ideal portion size
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Parental beliefs about child's maximum tolerated portion size
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Children's self-reported ideal portion size
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Children's self-reported maximum tolerated portion size
Number of subjects: 217
Study: 26661467

Group type: EXPERIMENTAL
Intervention: Rehabilitation program (28 sessions focused on mobility, balance, and gait exercises)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study: 25143156

Group type: EXPERIMENTAL
Intervention: Online intervention features including weight-gain tracker, health-related articles, blogs, physical activity and diet goal-setting tools, and local resources.
Number of subjects: 1014

Group type: EXPERIMENTAL
Intervention: Online intervention features
Number of subjects: 1014
Study: 21939492

Group type: EXPERIMENTAL
Intervention: PCA3 at first repeat biopsy
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: %fPSA at second repeat biopsy
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: %fPSA at ≥ third repeat biopsy
Number of subjects: 127

Group type: COMPARATOR
Intervention: tPSA
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: PSAV at second and ≥ third repeat biopsy
Number of subjects: 127
Study: 20510634

Group type: EXPERIMENTAL
Intervention: Energy delivery during endovenous laser therapy (EVLT), mean energy delivery 89.8 J/cm (range 44.5-158.4 J/cm)
Number of subjects: 232
Study: 18555161

Group type: EXPERIMENTAL
Intervention: Sleep protocol intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual nighttime care (Control)
Number of subjects: 0
Study: 15762903

Group type: EXPERIMENTAL
Intervention: Guideline-based care suggestions delivered to physicians and pharmacists when writing orders or filling prescriptions using computer workstations.
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Physicians receiving the intervention (care suggestions).
Number of subjects: 706

Group type: COMPARATOR
Intervention: Control group (no care suggestions).
Number of subjects: 706
Study: 12090977

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 9366

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 9366

Group type: COMPARATOR
Intervention: Combination of anastrozole plus tamoxifen
Number of subjects: 9366
Study: 10711365

Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control group (homologous blood transfusion)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Intraoperative autotransfusion vs homologous transfusion
Number of subjects: 700
Study: 8954434

Group type: EXPERIMENTAL
Intervention: Foot orthoses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no orthoses initially)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Foot orthoses (after being supplied to control group)
Number of subjects: 0
Study: 2011161

Group type: EXPERIMENTAL
Intervention: Mifepristone (12.5 or 25 mg per kilogram of body weight)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mifepristone and Human Chorionic Gonadotropin (2000 IU)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (instead of mifepristone and human chorionic gonadotropin)
Number of subjects: 21
Study: 7139223

Group type: EXPERIMENTAL
Intervention: Pollen extract
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31462258

Group type: EXPERIMENTAL
Intervention: Baseline brachial-ankle pulse wave velocity (baPWV)
Number of subjects: 2429

Group type: EXPERIMENTAL
Intervention: Baseline baPWV (per SD increment)
Number of subjects: 2429

Group type: EXPERIMENTAL
Intervention: baPWV assessed as quartiles (≥ 15.9 m/s)
Number of subjects: 2429

Group type: EXPERIMENTAL
Intervention: Baseline baPWV (per SD increment) in participants with impaired fasting glucose (IFG)
Number of subjects: 2429

Group type: EXPERIMENTAL
Intervention: Baseline baPWV (per SD increment) in participants without impaired fasting glucose (IFG)
Number of subjects: 2429
Study: 28049268

Group type: COMPARATOR
Intervention: Food Supplementation (FS)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Food Supplementation and Psychosocial Stimulation (FS+PS)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Control Group (CG)
Number of subjects: 355
Study: 25487904

Group type: EXPERIMENTAL
Intervention: Concentric glenoid wear pattern
Number of subjects: 309

Group type: COMPARATOR
Intervention: Eccentric glenoid wear pattern
Number of subjects: 309
Study: 22752296

Group type: EXPERIMENTAL
Intervention: Dentifrice containing PVM/MA copolymer
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (dentifrice without PVM/MA copolymer)
Number of subjects: 15
Study: 21367626

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 26
Study: 19378223

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg bid
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 17374691

Group type: EXPERIMENTAL
Intervention: Meat supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plain githeri
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milk supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no feedings)
Number of subjects: 0
Study: 12608522

Group type: EXPERIMENTAL
Intervention: Intentional weight loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term weight loss benefits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unintentional weight loss
Number of subjects: 0
Study: 10487175

Group type: EXPERIMENTAL
Intervention: Video game play
Number of subjects: 212

Group type: COMPARATOR
Intervention: Leisure activities (reading, physical exercise, puzzles, etc.)
Number of subjects: 212
Study: 8945079

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 1930923

Group type: EXPERIMENTAL
Intervention: 3 bouts of exercise/week for a total of 90 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7 bouts of exercise/week for a total of 210 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-week exercise in winter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7-week exercise in winter
Number of subjects: 0

Group type: COMPARATOR
Intervention: No added exercise in summer
Number of subjects: 0
Study: 6119183

Group type: EXPERIMENTAL
Intervention: BM 12.434
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metipranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of metipranolol and isosorbide‐5‐mononitrate
Number of subjects: 0
Study: 31504419

Group type: EXPERIMENTAL
Intervention: Uninterrupted edoxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin K antagonists
Number of subjects: 0
Study: 28652279

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 25561280

Group type: EXPERIMENTAL
Intervention: Open reduction using a plate
Number of subjects: 492

Group type: COMPARATOR
Intervention: Minimally invasive cannulated screw fixation
Number of subjects: 492
Study: 23789885

Group type: EXPERIMENTAL
Intervention: High-MW β-glucan (4 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-MW β-glucan (4 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 250 ml β-glucan beverage
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 600 ml β-glucan beverage
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All β-glucan beverages
Number of subjects: 15
Study: 22022222

Group type: EXPERIMENTAL
Intervention: Learning style-tailored education materials (information prescriptions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care discharge instructions
Number of subjects: 0
Study: 19226535

Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion (RTD) administered within an amino acid drink lacking tryptophan
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion (RTD)
Number of subjects: 17
Study: 16445305

Group type: EXPERIMENTAL
Intervention: Bemiparin plus oral anticoagulants (OAC) for 3 months
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Long-term bemiparin for 3 months
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) plus OAC
Number of subjects: 1000
Study: 14727208

Group type: EXPERIMENTAL
Intervention: Amphotericin B deoxycholate (1 mg/kg on alternate days for 30 days)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (2 mg/kg per day for 5 days)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (2 mg/kg per day for 5 days)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Amphotericin B deoxycholate
Number of subjects: 153

Group type: COMPARATOR
Intervention: Liposomal amphotericin B
Number of subjects: 153

Group type: COMPARATOR
Intervention: Amphotericin B lipid complex
Number of subjects: 153
Study: 10687755

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 400 microg
Number of subjects: 863

Group type: COMPARATOR
Intervention: Oxytocin/Syntometrine
Number of subjects: 863
Study: 7861499

Group type: EXPERIMENTAL
Intervention: Electrohydraulic lithotripsy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pneumatic lithotripsy
Number of subjects: 72
Study: 1783915

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Folic acid (Control)
Number of subjects: 42
Study: 7013957

Group type: EXPERIMENTAL
Intervention: Cephradine intravenously in the perioperative period (group 1)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Metronidazole and erythromycin base orally before operation (group 2)
Number of subjects: 130
Study: 31169149

Group type: EXPERIMENTAL
Intervention: Musical toothbrush
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular toothbrush
Number of subjects: 100
Study: 29776326

Group type: EXPERIMENTAL
Intervention: Hum Test (high pitched humming)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Hum Test (low pitched humming)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Weber Test
Number of subjects: 29
Study: 27253146

Group type: EXPERIMENTAL
Intervention: Conventional technique with rotary instruments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atraumatic restorative technique (ART)
Number of subjects: 0
Study: 23430578

Group type: EXPERIMENTAL
Intervention: Family program and school program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family program with high attendance
Number of subjects: 0

Group type: COMPARATOR
Intervention: School program
Number of subjects: 0
Study: 22776409

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (defined as serum 25(OH)vitamin D <20 ng/mL)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency
Number of subjects: 499
Study: 20356486

Group type: EXPERIMENTAL
Intervention: 7-day levofloxacin-based triple therapy (amoxicillin, levofloxacin, lansoprazole)
Number of subjects: 300

Group type: COMPARATOR
Intervention: 7-day standard triple therapy (clarithromycin, amoxicillin, lansoprazole)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study: 16647240

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: No drug
Number of subjects: 15
Study: 15661835

Group type: EXPERIMENTAL
Intervention: Submaximal exercise with reduced blood flow
Number of subjects: 9

Group type: COMPARATOR
Intervention: Submaximal exercise without blood flow restriction
Number of subjects: 9
Study: 12107601

Group type: EXPERIMENTAL
Intervention: Suplatast tosilate (100 mg three times daily)
Number of subjects: 20
Study: 10095821

Group type: EXPERIMENTAL
Intervention: 800 micrograms day‐1 of inhaled budesonide
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 1600 micrograms day‐1 of inhaled budesonide
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 800 micrograms day‐1 of inhaled budesonide plus placebo
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 40 mg day‐1 of prednisone
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 7477193

Group type: EXPERIMENTAL
Intervention: High-dose nadroparin (4100 anti-factor Xa IU twice daily)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Low-dose nadroparin (4100 IU once daily)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 31240513

Group type: COMPARATOR
Intervention: 1% PVP-I (Cohort A)
Number of subjects: 102

Group type: COMPARATOR
Intervention: 2% PVP-I (Cohort B)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Vehicle-control (Cohort C)
Number of subjects: 102
Study: 27682985

Group type: EXPERIMENTAL
Intervention: Portable electronic vision enhancement system (p‐EVES)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Optical low vision aids (LVA)
Number of subjects: 82
Study: 24484373

Group type: EXPERIMENTAL
Intervention: Online cognitive-behavioral therapy (CBT) for pain management + standard care (n = 17)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Wait-list control condition (n = 16)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Online cognitive-behavioral therapy (CBT) for pain management
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Shorter pretreatment sleep duration
Number of subjects: 33
Study: 23352524

Group type: EXPERIMENTAL
Intervention: Belief in God's role in health
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among African American patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among white patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among children
Number of subjects: 0
Study: 22100010

Group type: EXPERIMENTAL
Intervention: Managing Oral Hygiene Using Threat Reduction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard mouth care
Number of subjects: 80
Study: 19018805

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus tri‐iodothyronine (T(3))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychiatric counselling
Number of subjects: 0
Study: 17846333

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional abdominal aortic aneurysm repair (control)
Number of subjects: 82
Study: 15565603

Group type: EXPERIMENTAL
Intervention: 180 mug pegylated interferon alpha‐2a once weekly plus daily ribavirin
Number of subjects: 39
Study: 11686357

Group type: EXPERIMENTAL
Intervention: Enoxaparin (3000 IU anti-Xa as an i.v. bolus, followed by 70 IU anti-Xa/Kg every 8 h for 3 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Unfractionated heparin (100 IU/kg bolus followed by infusion for 3 days, titrated to maintain aPTT between 70 and 90 s)
Number of subjects: 45
Study: 9151268

Group type: EXPERIMENTAL
Intervention: Composite veneer materials
Number of subjects: 18
Study: 7874374

Group type: EXPERIMENTAL
Intervention: Pancuronium (0.1 mg/kg i.v.)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pipecuronium (0.07 mg/kg i.v.)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pancuronium and Pipecuronium (both groups)
Number of subjects: 80
Study: 2896868

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (12 g L-leucine, 8 g L-isoleucine, 6.4 g L-valine)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 29080948

Group type: EXPERIMENTAL
Intervention: ERAS
Number of subjects: 289

Group type: COMPARATOR
Intervention: CRAS
Number of subjects: 289
Study: 27459236

Group type: EXPERIMENTAL
Intervention: Frailty screening intervention followed by usual care from a general practitioner
Number of subjects: 3092

Group type: EXPERIMENTAL
Intervention: Nurse‐led care program (comprehensive geriatric assessment, evidence‐based care planning, care coordination, and follow‐up)
Number of subjects: 3092

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3092
Study: 25594611

Group type: COMPARATOR
Intervention: tanezumab 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: tanezumab 50 μg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: tanezumab 200 μg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 24391768

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine (Gardasil™)
Number of subjects: 1335
Study: 20736471

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Relaxation with educational support
Number of subjects: 86
Study: 18436090

Group type: COMPARATOR
Intervention: Standard dialysis regimen (4 hours 3 times weekly)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 4.5 hours of hemodialysis
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hemodialysis with increased dialysate flow
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hemodialysis with 2 dialyzers in parallel
Number of subjects: 18
Study: 15902180

Group type: EXPERIMENTAL
Intervention: End-to-end repair
Number of subjects: 41

Group type: COMPARATOR
Intervention: Overlapping repair
Number of subjects: 41
Study: 12507780

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study: 10930964

Group type: EXPERIMENTAL
Intervention: Elixir (30-40 mg kg-1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glycogelatin capsule suppository (30-40 mg kg-1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triglyceride base suppository (30-40 mg kg-1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Elixir
Number of subjects: 30
Study: 8664843

Group type: EXPERIMENTAL
Intervention: Aero-bars (AB)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Brake hoods (BH)
Number of subjects: 11
Study: 1994118

Group type: EXPERIMENTAL
Intervention: Cocaine users
Number of subjects: 224

Group type: COMPARATOR
Intervention: No recent cocaine use
Number of subjects: 224
Study: 6527524

Group type: EXPERIMENTAL
Intervention: 1.6 km jogging
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3.2 km jogging
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4.8 km jogging
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-jogging (control)
Number of subjects: 40
Study: 31648910

Group type: EXPERIMENTAL
Intervention: Two doses of quadrivalent HPV vaccine at 6 months interval
Number of subjects: 0
Study: 29580537

Group type: EXPERIMENTAL
Intervention: Combined ultrasound (US) and high-pressure homogenization (HPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-pressure homogenization (HPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultrasound (US)
Number of subjects: 0
Study: 26608718

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 24522201

Group type: EXPERIMENTAL
Intervention: Quinine MR with 10 mg rifampicin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quinine MR with 20 mg rifampicin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quinine MR with 100 mg rifampicin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Midazolam clearance
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 4β-hydroxycholesterol/cholesterol ratio
Number of subjects: 24
Study: 22314455

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia
Number of subjects: 60
Study: 20100142

Group type: EXPERIMENTAL
Intervention: IM‐MS irradiation
Number of subjects: 3866

Group type: COMPARATOR
Intervention: Control (no IM‐MS irradiation)
Number of subjects: 3866
Study: 17617944

Group type: EXPERIMENTAL
Intervention: LC1 fermented milk (373 kJ (89 kcal)/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (373 kJ/d of the same EN)
Number of subjects: 24
Study: 15139942

Group type: EXPERIMENTAL
Intervention: Intravenous patient-controlled-analgesia
Number of subjects: 125

Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 125
Study: 11813383

Group type: EXPERIMENTAL
Intervention: Rinsing with a higher volume of water (10 x 3 mL)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rinsing with a lower volume of water (5 mL)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rinsing duration of 10 seconds
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rinsing duration of 60 seconds
Number of subjects: 21
Study: 9601831

Group type: EXPERIMENTAL
Intervention: Subthreshold TENS (frequency 35 Hz, pulse width 100 milliseconds, modulation 50%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 10